Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes

An HIV vaccine capable of eliciting durable neutralizing antibody responses continues to be an important unmet need. Multivalent nanoparticles displaying a high density of envelope trimers may be promising immunogen forms to elicit strong and durable humoral responses to HIV, but critical particle d...

Full description

Bibliographic Details
Main Authors: Kulp, Daniel W., Mutafyan, Andrew A., Jones, Christopher A., Menis, Sergey, Georgeson, Erik, Kubitz, Mike, Zhang, Michael H., Melo, Mariane B., Silva, Murillo, Yun, Dong Soo, Schief, William R., Tokatlian, Talar, Irvine, Darrell J
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Published: Nature Publishing Group 2019
Online Access:http://hdl.handle.net/1721.1/120844
https://orcid.org/0000-0001-8452-6752
_version_ 1810975982185611264
author Kulp, Daniel W.
Mutafyan, Andrew A.
Jones, Christopher A.
Menis, Sergey
Georgeson, Erik
Kubitz, Mike
Zhang, Michael H.
Melo, Mariane B.
Silva, Murillo
Yun, Dong Soo
Schief, William R.
Tokatlian, Talar
Irvine, Darrell J
author2 Massachusetts Institute of Technology. Department of Biological Engineering
author_facet Massachusetts Institute of Technology. Department of Biological Engineering
Kulp, Daniel W.
Mutafyan, Andrew A.
Jones, Christopher A.
Menis, Sergey
Georgeson, Erik
Kubitz, Mike
Zhang, Michael H.
Melo, Mariane B.
Silva, Murillo
Yun, Dong Soo
Schief, William R.
Tokatlian, Talar
Irvine, Darrell J
author_sort Kulp, Daniel W.
collection MIT
description An HIV vaccine capable of eliciting durable neutralizing antibody responses continues to be an important unmet need. Multivalent nanoparticles displaying a high density of envelope trimers may be promising immunogen forms to elicit strong and durable humoral responses to HIV, but critical particle design criteria remain to be fully defined. To this end, we developed strategies to covalently anchor a stabilized gp140 trimer, BG505 MD39, on the surfaces of synthetic liposomes to study the effects of trimer density and vesicle stability on vaccine-elicited humoral responses in mice. CryoEM imaging revealed homogeneously distributed and oriented MD39 on the surface of liposomes irrespective of particle size, lipid composition, and conjugation strategy. Immunization with covalent MD39-coupled liposomes led to increased germinal center and antigen-specific T follicular helper cell responses and significantly higher avidity serum MD39-specific IgG responses compared to immunization with soluble MD39 trimers. A priming immunization with liposomal-MD39 was important for elicitation of high avidity antibody responses, regardless of whether booster immunizations were administered with either soluble or particulate trimers. The stability of trimer anchoring to liposomes was critical for these effects, as germinal center and output antibody responses were further increased by liposome compositions incorporating sphingomyelin that exhibited high in vitro stability in the presence of serum. Together these data highlight key liposome design features for optimizing humoral immunity to lipid nanoparticle immunogens.
first_indexed 2024-09-23T08:48:01Z
format Article
id mit-1721.1/120844
institution Massachusetts Institute of Technology
last_indexed 2024-09-23T08:48:01Z
publishDate 2019
publisher Nature Publishing Group
record_format dspace
spelling mit-1721.1/1208442022-09-23T14:39:06Z Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes Kulp, Daniel W. Mutafyan, Andrew A. Jones, Christopher A. Menis, Sergey Georgeson, Erik Kubitz, Mike Zhang, Michael H. Melo, Mariane B. Silva, Murillo Yun, Dong Soo Schief, William R. Tokatlian, Talar Irvine, Darrell J Massachusetts Institute of Technology. Department of Biological Engineering Massachusetts Institute of Technology. Department of Materials Science and Engineering Koch Institute for Integrative Cancer Research at MIT Tokatlian, Talar Irvine, Darrell J An HIV vaccine capable of eliciting durable neutralizing antibody responses continues to be an important unmet need. Multivalent nanoparticles displaying a high density of envelope trimers may be promising immunogen forms to elicit strong and durable humoral responses to HIV, but critical particle design criteria remain to be fully defined. To this end, we developed strategies to covalently anchor a stabilized gp140 trimer, BG505 MD39, on the surfaces of synthetic liposomes to study the effects of trimer density and vesicle stability on vaccine-elicited humoral responses in mice. CryoEM imaging revealed homogeneously distributed and oriented MD39 on the surface of liposomes irrespective of particle size, lipid composition, and conjugation strategy. Immunization with covalent MD39-coupled liposomes led to increased germinal center and antigen-specific T follicular helper cell responses and significantly higher avidity serum MD39-specific IgG responses compared to immunization with soluble MD39 trimers. A priming immunization with liposomal-MD39 was important for elicitation of high avidity antibody responses, regardless of whether booster immunizations were administered with either soluble or particulate trimers. The stability of trimer anchoring to liposomes was critical for these effects, as germinal center and output antibody responses were further increased by liposome compositions incorporating sphingomyelin that exhibited high in vitro stability in the presence of serum. Together these data highlight key liposome design features for optimizing humoral immunity to lipid nanoparticle immunogens. National Institute of Allergy and Infectious Diseases (U.S.) (Award UM1AI100663) National Institutes of Health (U.S.) (Award P01-AI104715) National Institutes of Health (U.S.) (Award P01-AI048240) National Cancer Institute (U.S.) (Grant P30-CA14051) 2019-03-08T20:58:10Z 2019-03-08T20:58:10Z 2018-11 2018-08 2019-02-15T15:48:02Z Article http://purl.org/eprint/type/JournalArticle 2045-2322 http://hdl.handle.net/1721.1/120844 Tokatlian, Talar et al. “Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes.” Scientific Reports 8, 1 (November 2018): 16527 © 2018 The Author(s) https://orcid.org/0000-0001-8452-6752 http://dx.doi.org/10.1038/s41598-018-34853-2 Scientific Reports Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/pdf Nature Publishing Group Scientific Reports
spellingShingle Kulp, Daniel W.
Mutafyan, Andrew A.
Jones, Christopher A.
Menis, Sergey
Georgeson, Erik
Kubitz, Mike
Zhang, Michael H.
Melo, Mariane B.
Silva, Murillo
Yun, Dong Soo
Schief, William R.
Tokatlian, Talar
Irvine, Darrell J
Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes
title Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes
title_full Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes
title_fullStr Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes
title_full_unstemmed Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes
title_short Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes
title_sort enhancing humoral responses against hiv envelope trimers via nanoparticle delivery with stabilized synthetic liposomes
url http://hdl.handle.net/1721.1/120844
https://orcid.org/0000-0001-8452-6752
work_keys_str_mv AT kulpdanielw enhancinghumoralresponsesagainsthivenvelopetrimersviananoparticledeliverywithstabilizedsyntheticliposomes
AT mutafyanandrewa enhancinghumoralresponsesagainsthivenvelopetrimersviananoparticledeliverywithstabilizedsyntheticliposomes
AT joneschristophera enhancinghumoralresponsesagainsthivenvelopetrimersviananoparticledeliverywithstabilizedsyntheticliposomes
AT menissergey enhancinghumoralresponsesagainsthivenvelopetrimersviananoparticledeliverywithstabilizedsyntheticliposomes
AT georgesonerik enhancinghumoralresponsesagainsthivenvelopetrimersviananoparticledeliverywithstabilizedsyntheticliposomes
AT kubitzmike enhancinghumoralresponsesagainsthivenvelopetrimersviananoparticledeliverywithstabilizedsyntheticliposomes
AT zhangmichaelh enhancinghumoralresponsesagainsthivenvelopetrimersviananoparticledeliverywithstabilizedsyntheticliposomes
AT melomarianeb enhancinghumoralresponsesagainsthivenvelopetrimersviananoparticledeliverywithstabilizedsyntheticliposomes
AT silvamurillo enhancinghumoralresponsesagainsthivenvelopetrimersviananoparticledeliverywithstabilizedsyntheticliposomes
AT yundongsoo enhancinghumoralresponsesagainsthivenvelopetrimersviananoparticledeliverywithstabilizedsyntheticliposomes
AT schiefwilliamr enhancinghumoralresponsesagainsthivenvelopetrimersviananoparticledeliverywithstabilizedsyntheticliposomes
AT tokatliantalar enhancinghumoralresponsesagainsthivenvelopetrimersviananoparticledeliverywithstabilizedsyntheticliposomes
AT irvinedarrellj enhancinghumoralresponsesagainsthivenvelopetrimersviananoparticledeliverywithstabilizedsyntheticliposomes